There was also monosomy or copy-neutral loss of heterozygosity of chromosome 17q in the majority of gliomas across both molecular groups that functioned as the mechanism for eliminating the remaining wild-type NF1 allele located at 17q11.2. This evidence concerns the gene NF1 and central nervous system cancer.